Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2018, Article ID 6970407, 10 pages
https://doi.org/10.1155/2018/6970407
Research Article

PPARγ Antagonizes Hypoxia-Induced Activation of Hepatic Stellate Cell through Cross Mediating PI3K/AKT and cGMP/PKG Signaling

1Department of Clinical Laboratory, Kunshan First People’s Hospital, Affiliated to Jiangsu University, Kunshan, Jiangsu Province 215300, China
2Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200336, China
3Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Correspondence should be addressed to Qinghui Zhang; moc.621@3891iuhgniqgnahz and Xiaojie Lu; nc.ude.uhw@981

Received 10 August 2017; Accepted 20 December 2017; Published 1 March 2018

Academic Editor: Antonio Brunetti

Copyright © 2018 Qinghui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Seki and R. F. Schwabe, “Hepatic inflammation and fibrosis: functional links and key pathways,” Hepatology, vol. 61, no. 3, pp. 1066–1079, 2015. View at Publisher · View at Google Scholar
  2. R. Bataller and D. A. Brenner, “Liver fibrosis,” The Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Seki and D. A. Brenner, “Recent advancement of molecular mechanisms of liver fibrosis,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 22, no. 7, pp. 512–518, 2015. View at Publisher · View at Google Scholar
  4. R. Weiskirchen and F. Tacke, “Liver fibrosis: from pathogenesis to novel therapies,” Digestive Diseases, vol. 34, no. 4, pp. 410–422, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Jia, C. Wu, J. Kim, B. Kim, and S.-J. Lee, “Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt,” The Journal of Nutritional Biochemistry, vol. 28, pp. 9–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Zhou, J. Wang, L. N. He et al., “Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ,” Experimental and Therapeutic Medicine, vol. 13, no. 2, pp. 780–786, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Jin, N. Lian, F. Zhang et al., “Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence,” Cell Death & Disease, vol. 7, no. 4, pp. e2189–e2189, 2016. View at Publisher · View at Google Scholar
  8. Z. Liu, W. Dou, Y. Zheng et al., “Curcumin upregulates Nrf2 nuclear translocation and protects rat hepatic stellate cells against oxidative stress,” Molecular Medicine Reports, vol. 13, no. 2, pp. 1717–1724, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Wang, Y. Huang, F. Guan et al., “Hypoxia-inducible factor-1alpha and mapk co-regulate activation of hepatic stellate cells upon hypoxia stimulation,” PLoS ONE, vol. 8, no. 9, Article ID e74051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. L. Copple, S. Bai, L. D. Burgoon, and J.-O. Moon, “Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis,” Liver International, vol. 31, no. 2, pp. 230–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Zhan, C. Huang, X.-M. Meng et al., “Hypoxia-inducible factor-1alpha in hepatic fibrosis: a promising therapeutic target,” Biochimie, vol. 108, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Wang, G. Li, Z. Yang et al., “Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer,” Oncotarget, vol. 8, no. 5, pp. 8083–8094, 2017. View at Publisher · View at Google Scholar
  13. Q. Jiang, W. Lu, K. Yang et al., “Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis,” American Journal of Physiology-Cell Physiology, vol. 311, no. 1, pp. C136–C149, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Brunt, “Nonalcoholic steatohepatitis: definition and pathology,” Seminars in Liver Disease, vol. 21, no. 3, pp. 3–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. Q.-H. Zhang, Y.-L. Yao, X.-Y. Wu et al., “Anti-miR-362-3p inhibits migration and invasion of human gastric cancer cells by its target CD82,” Digestive Diseases and Sciences, vol. 60, no. 7, pp. 1967–1976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Guan, F. Cheng, H. Wu et al., “GATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cells,” Journal of Cellular and Molecular Medicine, vol. 21, no. 3, pp. 568–578, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Zhang, D. Kong, Y. Lu, and S. Zheng, “Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside,” Cellular and Molecular Life Sciences, vol. 70, no. 2, pp. 259–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ogawa, M. Yoneda, W. Tomeno, K. Imajo, and Y. Shinohara, “Peroxisome proliferator-activated receptor gamma exacerbates concanavalin a-induced liver injury via suppressing the translocation of NF-κB into the nucleus,” PPAR Research, vol. 2012, Article ID 940384, 5 pages, 2012. View at Publisher · View at Google Scholar
  20. S. C. Iyer, A. Kannan, A. Gopal, N. Devaraj, and D. Halagowder, “Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition,” Experimental Cell Research, vol. 336, no. 1, pp. 66–75, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Jin, Y. Bai, H. Ni et al., “Activation of autophagy through calcium-dependent AMPK/mTOR and PKCθ pathway causes activation of rat hepatic stellate cells under hypoxic stress,” FEBS Letters, vol. 590, no. 5, pp. 672–682, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Mueller, “Does pressure cause liver cirrhosis? the sinusoidal pressure hypothesis,” World Journal of Gastroenterology, vol. 22, no. 48, pp. 10482–10501, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Ceni, T. Mello, S. Polvani et al., “The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells,” Journal of Hepatology, vol. 66, no. 4, pp. 754–764, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Risør, M. Fenger, N. V. Olsen, and S. Møller, “Hepatic erythropoietin response in cirrhosis,” Scandinavian Journal of Clinical & Laboratory Investigation, vol. 76, no. 3, pp. 234–239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Lecarpentier, V. Claes, A. Vallée, and J. Hébert, “Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway,” linical and Translational Medicine, vol. 6, no. 1, p. 14, 2017. View at Publisher · View at Google Scholar
  26. Z. Ge, P. Zhang, T. Hong et al., “Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation,” Scientific Reports, vol. 5, Article ID 17878, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. E. Zuckermann, R. M. La Ragione, D. L. Baines, and R. S. B. Williams, “Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model,” British Journal of Pharmacology, vol. 172, no. 22, pp. 5306–5317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Kilter, M. Werner, C. Roggia et al., “The PPAR-γ agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation,” Diabetes, Obesity and Metabolism, vol. 11, no. 11, pp. 1060–1067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Goetze, F. Eilers, A. Bungenstock et al., “PPAR activators inhibit endothelial cell migration by targeting Akt,” Biochemical and Biophysical Research Communications, vol. 293, no. 5, pp. 1431–1437, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Costa, D. Foti, F. Paonessa et al., “The insulin receptor: A new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione- PPARγ agonists,” Endocrine-Related Cancer, vol. 15, no. 1, pp. 325–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Trayhurn, “Hypoxia and adipose tissue function and dysfunction in obesity,” Physiological Reviews, vol. 93, no. 1, pp. 1–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Greco, E. Chiefari, T. Montalcini et al., “Early effects of a hypocaloric, mediterranean diet on laboratory parameters in obese individuals,” Mediators of Inflammation, vol. 2014, Article ID 750860, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus